Introduction: Hypercholesterolemia (HC) is an important cardiovascular risk factor associated with impaired neovascularization in response to ischemia. We found that specific microRNAs (miRs) whose levels are reduced in ischemic skeletal muscles of mice exposed to HC can rescue endothelial cell function and neovascularization. miRs can be transferred between cells via extracellular vesicles (EVs). EVs are involved in several biological functions including the response to ischemia and angiogenesis. Hypothesis: Here we tested the hypothesis that HC causes alterations in the miR content of EVs related to ischemia/neovascularization. Methods: We used a mouse model of peripheral artery disease to induce severe ischemia in the hindlimbs of hypercholesterolemic ApoE -/- and control C57Bl/6J mice. Microvesicles (MVs) and exosomes (exo) were isolated from ischemic skeletal muscles by differential centrifugation. Total RNA was extracted from these 2 types of EVs, and the miR content was analyzed using next generation sequencing. Results: Bioinformatic analysis of the 100 most expressed miRs in EVs showed an enrichment of 38 miRs in MVs compared to ischemic skeletal muscles, and an enrichment of 44 miRs in exo compared to ischemic skeletal muscles. Among enriched miRs, 27 are common to both MVs and exo. We identified specific miRs enriched in EVs that are known to modulate angiogenesis, including several miRs that were altered by HC. For example, among enriched miRs downregulated by HC in EVs, the let-7 family and miR-29a are known to be pro-angiogenic via inhibition of members of the TIMP family. On the other hand, among enriched miRs upregulated by HC in EVs, miR-199a and miR-16-5p are known to be anti-angiogenic via inhibition of VEGF. Conclusions: This study describes for the first time the effect of HC on the modulation of miR profile in EVs following skeletal muscle ischemia. We found that several angiogenesis-modulating miRs are enriched in EVs and altered by HC. Our findings constitute a solid framework for the identification of miRs that could be targeted to modify EV content in atherosclerotic conditions. Eventually these engineered EVs could serve as vectors to promote neovascularization and reduce ischemic damages in severe vascular diseases.
Read full abstract